These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 10428223)

  • 1. Bleeding complications with enoxaparin for deep venous thrombosis prophylaxis.
    Shaieb MD; Watson BN; Atkinson RE
    J Arthroplasty; 1999 Jun; 14(4):432-8. PubMed ID: 10428223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Postoperative Bleeding in Total Hip and Knee Arthroplasty Patients Receiving Rivaroxaban or Enoxaparin.
    Ricket AL; Stewart DW; Wood RC; Cornett L; Odle B; Cluck D; Freshour J; El-Bazouni H
    Ann Pharmacother; 2016 Apr; 50(4):270-5. PubMed ID: 26783354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of venous thromboembolic disease following primary total knee arthroplasty. A randomized, multicenter, open-label, parallel-group comparison of enoxaparin and warfarin.
    Fitzgerald RH; Spiro TE; Trowbridge AA; Gardiner GA; Whitsett TL; O'Connell MB; Ohar JA; Young TR;
    J Bone Joint Surg Am; 2001 Jun; 83(6):900-6. PubMed ID: 11407799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multimodal thromboprophylaxis for total hip and knee arthroplasty based on risk assessment.
    Dorr LD; Gendelman V; Maheshwari AV; Boutary M; Wan Z; Long WT
    J Bone Joint Surg Am; 2007 Dec; 89(12):2648-57. PubMed ID: 18056497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apixaban versus enoxaparin for thromboprophylaxis after hip or knee replacement: pooled analysis of major venous thromboembolism and bleeding in 8464 patients from the ADVANCE-2 and ADVANCE-3 trials.
    Raskob GE; Gallus AS; Pineo GF; Chen D; Ramirez LM; Wright RT; Lassen MR
    J Bone Joint Surg Br; 2012 Feb; 94(2):257-64. PubMed ID: 22323697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after elective major knee surgery.
    Bauer KA; Eriksson BI; Lassen MR; Turpie AG;
    N Engl J Med; 2001 Nov; 345(18):1305-10. PubMed ID: 11794149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the safety and efficacy of enoxaparin and warfarin for prevention of deep vein thrombosis after total knee arthroplasty.
    Stern SH; Wixson RL; O'Connor D
    J Arthroplasty; 2000 Feb; 15(2):153-8. PubMed ID: 10708078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Thromboprophylaxis with enoxaparin for total knee replacement: an observational, retrospective and multicentre study comparing starting the treatment before and after the operation].
    Llau JV; Gil-Garay E; Castellet E;
    Rev Esp Anestesiol Reanim; 2012; 59(6):306-14. PubMed ID: 22738999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrahepatic hemorrhage after use of low-molecular-weight heparin for total hip arthroplasty.
    Houde JP; Steinberg G
    J Arthroplasty; 1999 Apr; 14(3):372-4. PubMed ID: 10220193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolonged enoxaparin therapy to prevent venous thromboembolism after primary hip or knee replacement. Enoxaparin Clinical Trial Group.
    Comp PC; Spiro TE; Friedman RJ; Whitsett TL; Johnson GJ; Gardiner GA; Landon GC; Jové M;
    J Bone Joint Surg Am; 2001 Mar; 83(3):336-45. PubMed ID: 11263636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utilization Patterns, Efficacy, and Complications of Venous Thromboembolism Prophylaxis Strategies in Primary Hip and Knee Arthroplasty as Reported by American Board of Orthopedic Surgery Part II Candidates.
    Runner RP; Gottschalk MB; Staley CA; Pour AE; Roberson JR
    J Arthroplasty; 2019 Apr; 34(4):729-734. PubMed ID: 30685257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dabigatran: new drug. Continue to use heparin, a better-known option.
    Prescrire Int; 2009 Jun; 18(101):97-9. PubMed ID: 19637411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Enoxaparin and Rivaroxaban in Balance of Anti-Fibrinolysis and Anticoagulation Following Primary Total Knee Replacement: A Pilot Study.
    Xie J; Ma J; Huang Q; Yue C; Pei F
    Med Sci Monit; 2017 Feb; 23():704-711. PubMed ID: 28174415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma tissue factor pathway inhibitor levels as a marker for postoperative bleeding after enoxaparin use in deep vein thrombosis prophylaxis in orthopedics and general surgery.
    Hakki SI; Fareed J; Hoppensteadt DA; Abdullah H; Camblin J; Nasseri AF; Hamadeh O; Wright T
    Clin Appl Thromb Hemost; 2001 Jan; 7(1):65-71. PubMed ID: 11190908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A synthetic pentasaccharide for the prevention of deep-vein thrombosis after total hip replacement.
    Turpie AG; Gallus AS; Hoek JA;
    N Engl J Med; 2001 Mar; 344(9):619-25. PubMed ID: 11228275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the oral direct thrombin inhibitor ximelagatran with enoxaparin as prophylaxis against venous thromboembolism after total knee replacement: a phase 2 dose-finding study.
    Heit JA; Colwell CW; Francis CW; Ginsberg JS; Berkowitz SD; Whipple J; Peters G;
    Arch Intern Med; 2001 Oct; 161(18):2215-21. PubMed ID: 11575978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A retrospective analysis of bleeding risk with rivaroxaban, enoxaparin, and aspirin following total joint arthroplasty or revision.
    Watts PJ; Kopstein M; Harkness W; Cornett B; Dziadkowiec O; Hicks ME; Hassan S; Scherbak D
    Pharmacotherapy; 2021 Jul; 41(7):608-615. PubMed ID: 34050956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of postoperative pharmacologic thromboprophylaxis with enoxaparin after pancreatic surgery.
    Imamura H; Adachi T; Kitasato A; Tanaka T; Soyama A; Hidaka M; Fujita F; Takatsuki M; Kuroki T; Eguchi S
    Surg Today; 2017 Aug; 47(8):994-1000. PubMed ID: 28229301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative Effectiveness and Safety of Drug Prophylaxis for Prevention of Venous Thromboembolism After Total Knee Arthroplasty.
    Cafri G; Paxton EW; Chen Y; Cheetham CT; Gould MK; Sluggett J; Bini SA; Khatod M
    J Arthroplasty; 2017 Nov; 32(11):3524-3528.e1. PubMed ID: 28634095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma tissue factor pathway inhibitor levels as a marker for postoperative bleeding after enoxaparin use in deep vein thrombosis prophylaxis in orthopedics and general surgery.
    Hakki SI; Fareed J; Hoppensteadt DA; Abdullah H; Camblin J; Nasseri AF; Hamadeh O; Wright T
    Clin Appl Thromb Hemost; 2000 Oct; 6(4):206-12. PubMed ID: 11030526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.